Education, Science, Technology, Innovation and Life
Open Access
Sign In

Analysis on the Experience of Mishi Xiaoyu Decoction in Treating Gout of Spleen Deficiency and Phlegm Stasis

Download as PDF

DOI: 10.23977/medcm.2022.040108 | Downloads: 21 | Views: 772


Yue Li 1, Yang Xiao 2


1 The First Clinical Medical College of Shaanxi University of Chinese Medincine, Xianyang, Shaanxi, 712046, China
2 Shaanxi Provincial Hospital of Traditional Chinese Medicine, Second Department of Endocrinology, Xi'an, Shaanxi, 710003, China

Corresponding Author

Yang Xiao


Gout is called arthralgia syndrome in traditional Chinese medicine, and its symptoms are often discomfort such as redness, swelling, heat, pain, acid distension, activity disorder and so on. Doctors have different understanding of its etiology and pathogenesis. In his long-term clinical practice, Dr. Xiao Yang concluded that the etiology and pathogenesis of gout was "spleen deficiency, phlegm and blood stasis". Based on this, Mishi Xiaoyu Jiangzhuo decoction was designed to treat gout, mainly to reduce the symptoms of acute gout and prolong the interval. Reduce the frequency of acute attacks. In clinical practice, the prescription has different emphasis according to different stages of gout, age of patients, deficiency of vital qi, etc., such as pain relief in acute stage, recuperation of spleen, stomach, liver and kidney function during intermission, strengthening spleen and replenishing qi and reducing turbidity in young people, and removing blood stasis and reducing turbidity in middle-aged and elderly people, probably because young people do not decline, phlegm turbidity is heavy, blood stasis is light, fatigue is damaged in middle-aged and elderly people, and long-term illness leads to phlegm and blood stasis. In the treatment, we should also take into account the physiological status of spleen and stomach, liver and kidney deficiency, plus take care of the spleen and stomach, protect Yin fluid drugs, the following from the clinical treatment of medical records to provide ideas for the clinical application of traditional Chinese medicine in the treatment of gout.


Gout, Mishi Xiaoyu Jiangzhuo decoction, Spleen deficiency and phlegm stasis type, experience, Xiao Yang


Yue Li, Yang Xiao, Analysis on the Experience of Mishi Xiaoyu Decoction in Treating Gout of Spleen Deficiency and Phlegm Stasis. MEDS Chinese Medicine (2022) Vol. 4: 50-53. DOI:


[1] Fu Hengtao, Zhang Miao, Ci Xiaoyan, Cui Tao. Research progress of drugs for the treatment of gout and hyperuricemia [J]. Drug evaluation study, 2021, 44 (08): 1811-1816. 
[2] Jiang Quan, Han Man, Tang Xiaopo, Luo Chenggui and Gong Xun. Guidelines for the diagnosis and treatment of gout and hyperuricemia [J]. Journal of Traditional Chinese Medicine, 2021, 62 (14): 1276-1288. 
[3] Zhu Wanhua, Gu Dongmei, Jiang Tian, Zhu Liangchun. Turbid stasis-gout TCM disease name discussion [J]. Chinese medicine journal, 2011, 52 (17): 1521-1522. 
[4] Yang Jian, Fei Hongxin, Liu Xu, Roman, Li Baolong, Zhong Lili, Zhang Yingbo, Zhou Zhongguang. Overview of TCM treatment of hyperuricemia [J]. Heilongjiang Science, 2017, 8 (08): 86-87. 
[5] Wu Changyi, Chen Rui, Zhao Yang, Wu Ren Tuya, Jiang Mengyao, Yuan Feixia, Mei Qingqing, Zhang Huadong. Experience Summary and Extension of Li Jiren in Treating Gouty Arthritis [J]. Beijing Traditional Chinese Medicine, 2021, 40 (04): 334-337. 
[6] Hang Cheng, Xiao Yang, Qi Haiyan, Wang Gaolei, Ke Ting, Huang Qian, Han Ruiyun. Therapeutic effect of Mishi Xiaoyu Jiangzhuo Decoction on gouty arthritis in remission stage [J]. Shaanxi Traditional Chinese Medicine, 2019, 40 (10): 1407–1410. 
[7] Chen Chang, Xie Yongyan, Huang Liping. Research progress on pharmacological effects of lotus leaf alkaloids [J / OL]. Journal of Nanjing University of Traditional Chinese Medicine, 2021 (04): 619 – 624.

Downloads: 2993
Visits: 107475

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.